← Back to Clinical Trials
Recruiting NCT07499973

NCT07499973 Influence of Abdominal Muscle Function on Knee Stability for Injury Prevention

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07499973
Status Recruiting
Phase
Sponsor European University of Madrid
Condition Core Strength
Study Type INTERVENTIONAL
Enrollment 35 participants
Start Date 2026-03-06
Primary Completion 2026-07

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age 35 Years
Study Type INTERVENTIONAL
Interventions
Core Stabilization Training Program

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 35 participants in total. It began in 2026-03-06 with a primary completion date of 2026-07.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to learn whether an 8-week core stabilization training program can improve abdominal strength and knee stability in physically active women aged 18 to 35. The main questions it aims to answer are: Does core stabilization training improve abdominal endurance as measured by the Prone Bridge Test? Does this training enhance knee stability as measured by the Lateral Squat Down, Y-Balance Test, and Drop Vertical Jump? Researchers will compare participants' results before and after the intervention to see whether the training program leads to measurable improvements in strength and stability. Participants will: Complete baseline testing of abdominal strength and knee stability using standardized assessments (Prone Bridge Test, Lateral Squat Down, Y-Balance Test, Drop Vertical Jump) recorded with a Vicon motion-capture system. Perform an 8-week supervised core stabilization program that includes front plank, side plank, and Nordic hamstring exercises following a structured progression. Complete the same performance tests again after the intervention.

Eligibility Criteria

Inclusion Criteria: * Female participants * Age between 18 and 35 years * Performing regular physical activity ≥ 6 hours per week. * Able to complete all assessment procedures (Prone Bridge Test, Lateral Squat Down, Y-Balance Test, Drop Vertical Jump). * Willing to comply with the 8-week study procedures (training program or control condition) Exclusion Criteria: * Current musculoskeletal injury affecting the lower limbs, trunk, or spine * History of surgery in the lower limbs or spine in the past 12 months * Known neurological, cardiovascular, or systemic conditions that may interfere with physical testing * Pregnancy * Participation in any structured core-strengthening program during the study period * Inability to abstain from core training if assigned to the control group

Contact & Investigator

Central Contact

Marina Castel-Sánchez, PhD

✉ marina.castel@universidadeuropea.es

📞 +34679448994

Frequently Asked Questions

Who can join the NCT07499973 clinical trial?

This trial is open to female participants only, aged 18 Years or older, up to 35 Years, studying Core Strength. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07499973 currently recruiting?

Yes, NCT07499973 is actively recruiting participants. Contact the research team at marina.castel@universidadeuropea.es for enrollment information.

Where is the NCT07499973 trial being conducted?

This trial is being conducted at Villaviciosa de Odón, Spain.

Who is sponsoring the NCT07499973 clinical trial?

NCT07499973 is sponsored by European University of Madrid. The trial plans to enroll 35 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology